Bill Wright | executive |
Oleg Movchan | executive |
Neal Pawar | executive |
Bradley Herring | executive |
Michael Infante | analyst |
Faith Brunner | analyst |
Gabriela Borges | analyst |
Koji Ikeda | analyst |
Alexei Gogolev | analyst |
Matthew Kikkert | analyst |
Good afternoon, ladies and gentlemen. Thank you for standing by. Welcome to Enfusion Second Quarter 2024 Earnings Conference Call. [Operator instructions] As a reminder, this conference call is being recorded. I would now like to turn the call over to Bill Wright, Head of Investor Relations to begin.
Good morning, and thank you, operator.